Association of human leukocyte antigen and T cell message with human papillomavirus 16-positive cervical neoplasia in Japanese women

International Journal of Gynecological Cancer

Volumn 17, Issue 6, 2007, Pages 1314-1321

  Saito, M ^a,b   Okubo, M ^b   Hirata, R ^b   Takeda, S ^a   Maeda, H ^b  

^a Department of Obstetrics and Gynecology ^*  (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cervical neoplasia; Helper T cell; HLA DQ; HLA DR; Human papillomavirus

Indexed keywords

FAS LIGAND; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; LEUKOCYTE ANTIGEN;

ALLELE; ARTICLE; CELL ACTIVITY; CELL SPECIFICITY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HAPLOTYPE; HELPER CELL; HISTOCOMPATIBILITY COMPLEX; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNE RESPONSE; JAPANESE; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; FAS LIGAND PROTEIN; FEMALE; GENOTYPE; HLA ANTIGENS; HUMAN PAPILLOMAVIRUS 16; HUMANS; JAPAN; PERFORIN; RECEPTORS, ANTIGEN, T-CELL; RNA, MESSENGER; T-LYMPHOCYTES; UTERINE CERVICAL NEOPLASMS;

EID: 35948954664     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00938.x     Document Type: Article

References (29)

1. Bosch FX, Lorincz A, Munoz N, Meier CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002 55: 244 65.
2. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1996 1288: F55 78.
3. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 1992 23: 117 28.
4. Wright TC. Pathogenesis and diagnosis of preinvasive lesions of the lower genital tract. In: Hoskins WJ et al., eds. Principles and practice of gynecologic oncology, 3rd edn. Philadelphia: Lippincott Williams Wilkins, 2000: 735 74.
5. Bontkes HJ, Waboomers JMM, Meijer CJLM, Helmerhorst TJM, Stern PL. Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression. Lancet 1998 351: 187 8.
6. Cromme FV, Meijer CJ, Snijders PJ et al. Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. Br J Cancer 1993 67: 1372 80.
7. Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 1994 6: 157 62.
8. Apple RJ, Becker TM, Wheeler CM, Erlich HA. Comparison of human leukocyte antigen DR-DQ disease association found with cervical dysplasia and invasive cervical carcinoma. J Natl Cancer Inst 1995 87: 427 36.
9. Allen M, Kalantari M, Ylitalo N et al. HLA DQ-DR haplotype and susceptibility to cervical carcinoma in individuals infected with HPV 18. Tissue Antigens 1996 48: 32 7.
10. Sastre-Garau X, Loste MN, Vincent-Salomon A et al. Decreased frequency of HLA-DRB1*13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix. Int J Cancer 1996 69: 159 64.
11. Sanjeevi CB, Hjelmstrom Hallmans G et al. Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish woman. Int J Cancer 1996 68: 409 14.
12. Helland A, Olsen AO, Gjoen K et al. An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women. Int J Cancer 1998 76: 19 24.
13. Bontkes HJ, van Duin M, de Gruijl TD et al. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 1998 78: 166 71.
14. Hildesheim A, Schiffman M, Scott DR et al. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. Cancer Epidemiol Biomarkers Prev 1998 7: 1035 41.
15. Ferrera A, Olivo C, Alaez C, Melchers WJ, Gorodezky C. HLA DQA1 and DQB1 loci in Honduran woman with cervical carcinoma and their relationship to human papillomavirus infection. Hum Biol 1999 71: 367 79.
16. Maciag PC, Schlecht NF, Souza PS, Franco EL, Villa LL, Petzl-Erler ML. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol Biomarkers Prev 2000 9: 1183 91.
17. Cuzick J, Terry G, Ho L et al. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical in British women. Br J Cancer 2000 82: 1348 52.
18. Beskow AH, Josefsson AM, Gyllensten UB. HLA class II alleles associated with infection by HPV 16 in cervical cancer in situ. Int J Cancer 2001 93: 817 22.
19. Lin P, Koutsky LA, Critchlow CW et al. HLA class II DR-DQ and increased risk of cervical cancer among Senegalese woman. Cancer Epidemiol Biomarkers Prev 2001 10: 1037 45.
20. Zehbe I, Tachezy R, Mytilineos J, Gissmann L, Wilander E, Tommasino M. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 2001 94: 711 6.
21. Ghaderi M, Nikitina Zake L, Wallin K et al. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer. Hum Immunol 2001 62: 1153 8.
22. Wang SS, Wheeler CM, Hildesheim A et al. Human leukocyte antigen classes I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. J Infect Dis 2001 184: 1310 4.
23. Wang SS, Hildesheim A, Gao X et al. Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. J Infect Dis 2002 186: 598 605.
24. Madeleine MM, Brumback B, Cushing-Haugen KL et al. Human leukocyte antigen class II and cervical cancer risk: a population-based study. J Infect Dis 2002 186: 1565 74.
25. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikawa H, Iwamoto A. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 1991 82: 524 31.
26. Nishimoto T, Matsuki K, Islam MM, Hirata R, Maeda H. Unique associations between HLA-B and HLA-DRB1*04 gene variations in Japanese. Tissue Antigens 1993 42: 497 501.
27. Chan DPC, Cheung T-H, Tam AOY et al. Risk association between human leukocyte antigen-A allele and high-risk human papillomavirus infection for cervical neoplasia in Chinese Woman. J Infect Dis 2005 192: 1749 56.
28. Chan PKS, Cheung JLK, Cheung T-H et al. HLA-B alleles, high-risk HPV infection and risk for cervical neoplasia in southern Chinese women. Int J Cancer 2006 118: 1430 5.
29. American Collage of Obstetricians and Gynecologists. Evaluation and management of abnormal cervical cytology and histology in the adolescent. Obstet Gynecol 2006 107: 963 68.